{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:56:59Z","timestamp":1793005019375,"version":"4.5.0"},"reference-count":200,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cell Biochemistry &amp;amp; Function"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec><jats:label\/><jats:p>COVID\u201019 caused by SARS\u2010COV\u20102 first appeared in the Wuhan City of China and began to spread rapidly among people. Rapid progression of the outbreak has led to a major global public health problem of a potentially fatal disease. On January 30, 2020, WHO declared the pandemic as the sixth public health emergency of the world. Upon this, the whole country has started to take the necessary precautions. The new coronavirus uses membrane\u2010bound angiotensin\u2010converting enzyme 2 (ACE2) to enter into the cells, such as SARS\u2010CoV, and mostly affects the respiratory tract. Symptoms of COVID\u201019 patients include fever (93%), fatigue (70%), cough (70%), anorexia (40%) and dyspnoea (34.5%). The elderly and people with underlying chronic diseases are more susceptible to infection and higher mortality. Currently, a large number of drugs and vaccines studies are ongoing. In this review, we discussed the virology, epidemiological data, the replication of the virus, and its relationship with cardiovascular diseases on COVID\u201019 pandemics, treatment and vaccines. Thereby, this study aims to neatly present scientific data in light of many regarding literature that can be a clue for readers who research this disease prevention and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance of the study<\/jats:title><jats:p>This review summarized current information on COVID\u201019 (epidemiology, pathophysiology, clinical, laboratory, cardiovascular diseases, ACE2 and pharmacological agents) for researchers and reveals guiding data for researchers, especially in the field of cardiovascular system, pharmacology, dysregulation of cellular function in disease, molecular and cell biology and physiology in the regulation of tissue function in health and disease.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cbf.3591","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T19:55:22Z","timestamp":1601409322000},"page":"10-28","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["<scp>SARS\u2010COV<\/scp>\u20102 (<scp>COVID<\/scp>\u201019): Cellular and biochemical properties and pharmacological insights into new therapeutic developments"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-3468","authenticated-orcid":false,"given":"Hakan","family":"Parlakpinar","sequence":"first","affiliation":[{"name":"Department of Medical Pharmacology, Faculty of Medicine Inonu University  Malatya Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-4259","authenticated-orcid":false,"given":"Mehmet","family":"Gunata","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Faculty of Medicine Inonu University  Malatya Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","unstructured":"De GrootR BakerS BaricR et al. Family Coronaviridae.Ninth Report of the International Committee on Taxonomy of Viruses. Amsterdam: Elsevier Academic Press;2011:806\u2010828.","DOI":"10.1016\/B978-0-12-384684-6.00068-9"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000188166.17324.60"},{"key":"e_1_2_11_4_1","first-page":"120","volume-title":"Committee on Taxonomy of Viruses","year":"2015"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385885-6.00009-2"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11030210"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104211"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2003.00518.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33221-0"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"e_1_2_11_12_1","unstructured":"VANCOUVER. The coronavirus spreads racism against\u2014and among\u2014ethnic Chinese. February 17 2020.https:\/\/www.economist.com\/china\/2020\/02\/17\/the-coronavirus-spreads-racism-against-and-among-ethnic-chinese. Accessed March 28 2020."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.009"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104212"},{"key":"e_1_2_11_15_1","unstructured":"Organization WH. Novel coronavirus (2019\u2010nCoV) situation report\u20102.https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200122-sitrep-2-2019-ncov.pdf. Accessed January 21 2020."},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25701"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058"},{"key":"e_1_2_11_18_1","unstructured":"WHO Coronavirus Disease (COVID\u201019) Dashboard.https:\/\/covid19.who.int\/. Accessed August 21 2020."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104285"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25685"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104445"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-004-0219-0"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400759200"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104374"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-0233-6"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104327"},{"key":"e_1_2_11_28_1","unstructured":"Wuhan Coronavirus Death Rate.www.worldometers.info. Accessed February 2 2020."},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.004"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.050"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30260-9"},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","unstructured":"BackerJ KlinkenbergD WallingaJ.Incubation period of 2019 novel coronavirus (2019\u2010nCoV) infections among travellers from Wuhan China 20\u201028 January 2020.Euro Surveill.2020;25(5):1\u20106.","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01020"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020330"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13209"},{"key":"e_1_2_11_36_1","first-page":"1","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID\u201019) outbreak","volume":"102433","author":"Rothan HA","year":"2020","journal-title":"J Autoimmun"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924"},{"key":"e_1_2_11_38_1","first-page":"1","article-title":"Novel coronavirus: where we are and what we know","volume":"2020","author":"Cheng ZJ","year":"2019","journal-title":"Infection"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","unstructured":"China. Int J Infect Dis 2020 95 Statistical and network analysis of 1212 COVID\u201019 patients in Henan","DOI":"10.1016\/j.ijid.2020.04.051"},{"issue":"2","key":"e_1_2_11_42_1","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID\u201019) in China","volume":"41","author":"Novel CPERE","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi= Zhonghua Liuxingbingxue Zazhi"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565"},{"key":"e_1_2_11_44_1","unstructured":"COVID C. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID\u201019)\u2014United States February 12\u2010March 16 2020."},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25689"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30360-3"},{"key":"e_1_2_11_48_1","unstructured":"Disease background of COVID\u201019. ;https:\/\/www.ecdc.europa.eu\/en\/2019-ncov-background-disease. Accessed March 25 2020."},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.02.012"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047297"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00127-20"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aivir.2019.08.002"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.912134"},{"key":"e_1_2_11_54_1","unstructured":"Curr Top Microbiol Immunol 2005 287 Coronavirus transcription: a perspective"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5288-5295.2005"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008964"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0505577102"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104384"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2020.03.001"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_11_63_1","first-page":"1","article-title":"Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin","author":"Parlakpinar H","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.09.002"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-013-0178-0"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2013.11.017"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.01981.x"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3177"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0844(200001\/03)18:1<23::AID-CBF843>3.0.CO;2-0"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2015.08.007"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3092"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20060342"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040634"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00786"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200410000-00020"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000013847.07035.B9"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.3.665"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301077"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002450"},{"key":"e_1_2_11_82_1","unstructured":"AHA. Patients taking ACE\u2010i and ARBs who contract COVID 19 should continue treatment unless otherwise advised by their physician.https:\/\/newsroom.heart.org\/news\/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician. Accessed March 18 2020."},{"key":"e_1_2_11_83_1","unstructured":"Hypertension ESo. ESH Statement on COVID\u201019.https:\/\/www.eshonline.org\/spotlights\/esh-statement-on-covid-19. Accessed March 18 2020"},{"key":"e_1_2_11_84_1","unstructured":"Hypertension ISo. A statement from the International Society of Hypertension on COVID\u201019.https:\/\/ish-world.com\/news\/a\/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19. Accessed March 18 2020."},{"key":"e_1_2_11_85_1","unstructured":"EschnerK. Position statement of the ESC council on hypertension on ACE\u2010inhibitors and angiotensin receptor blockers.https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension(CHT)\/News\/position-statement-of-the-ESC-Council-on-hypertension-on-ace-inhibitors-and-ang. Accessed March 18 2020."},{"key":"e_1_2_11_86_1","unstructured":"CanadaH.Hypertension Canada\u2010statement on COVID\u201019.https:\/\/hypertension.ca\/wp-content\/uploads\/2020\/03\/2020-30-15-Hypertension-Canada\u2010Statement\u2010on\u2010COVID\u201019\u2010ACEi\u2010ARB.pdf. Accessed on March 18 2020."},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0193"},{"key":"e_1_2_11_88_1","unstructured":"JointGIsociety message: COVID\u201019 clinical insights for our community of gastroenterologists and gastroenterology care providers.https:\/\/www.gastro.org\/press-release\/joint-gi-societymessage-covid-19-clinical-insights-for-our-community-of-gastroenterologists-andgastroenterology-care-providers. Accessed March 18 2020."},{"key":"e_1_2_11_89_1","unstructured":"RheumatismTELA. EULAR Guidance for the patient's COVID\u201019 outbreak.https:\/\/www.eular.org\/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed March 18 2020."},{"key":"e_1_2_11_90_1","unstructured":"Dermatology TAAo. Dry Skin Relief From Covid\u201019 Handwashing.https:\/\/www.aad.org\/public\/everyday-care\/skin-care-basics\/dry\/coronavirus-handwashing. Accessed March 18 2020."},{"key":"e_1_2_11_91_1","unstructured":"Rheumatology ACo. March 18 2020."},{"key":"e_1_2_11_92_1","volume-title":"Covid\u201019: Ibuprofen Should Not Be Used for Managing Symptoms, Say Doctors and Scientists","author":"Day M","year":"2020"},{"key":"e_1_2_11_93_1","unstructured":"AlertS.Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID\u201019 Symptoms.https:\/\/www.sciencealert.com\/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms. Accessed March 19 2020."},{"key":"e_1_2_11_94_1","unstructured":"AgencyEM. EMA advises on the use of non\u2010steroidal anti\u2010inflammatories for COVID\u201019.https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Accessed March 19 2020."},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12586"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa231"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01626-9"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702090"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.004"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2020.03.001"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy462"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2016.78"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000744"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.3606"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.031"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024893"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1623"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"issue":"5","key":"e_1_2_11_122_1","first-page":"730","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV","volume":"215","year":"2020","journal-title":"Chembiochem"},{"key":"e_1_2_11_123_1","doi-asserted-by":"crossref","unstructured":"N Engl J Med 2020 382 First Case of 2019 Novel Coronavirus in the United States","DOI":"10.1056\/NEJMoa2001191"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105933"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105923"},{"key":"e_1_2_11_126_1","doi-asserted-by":"crossref","unstructured":"ChangR SunWZ. Repositioning Chloroquine as Ideal Antiviral Prophylactic against COVID\u201019\u2010Time is Now.2020.","DOI":"10.20944\/preprints202003.0279.v1"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.08.058"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.716100"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.03.005"},{"key":"e_1_2_11_130_1","first-page":"1","article-title":"Potential small\u2010molecule drugs as available weapons to fight novel coronavirus (2019\u2010nCoV): a review","author":"Rahimkhoei V","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"e_1_2_11_131_1","unstructured":"Biopharma products in development for COVID\u201019.https:\/\/www.bioworld.com\/COVID19products. Accessed August 3 2020."},{"key":"e_1_2_11_132_1","unstructured":"Medica SIoM. Chinese Academy of Sciences. A joint research team of the Shanghai Institute of Materia Medica and Shanghai Tech University discover a group of old and traditional Chinese medicines that may be efficacious in treating the novel form of pneumonia.http:\/\/www.simm.ac.cn\/xwzx\/kydt\/202001\/t20200125_5494417.html. Accessed February 22 2020."},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00240-0"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.37"},{"key":"e_1_2_11_135_1","first-page":"E002","article-title":"Potential antiviral therapeutics for 2019 novel coronavirus","volume":"43","author":"Li H","year":"2020","journal-title":"Zhonghua Jie he he Hu Xi Za Zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese J Tuberc Respir Dis"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17180"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6"},{"key":"e_1_2_11_139_1","unstructured":"RosaSGV SantosWC.Clinical trials on drug repositioning for COVID\u201019 treatment."},{"key":"e_1_2_11_140_1","unstructured":"BeechingNJ FT FowlerR. Update on COVID\u201019 pandemic.https:\/\/bestpractice.bmj.com\/topics\/en-gb\/3000168#important-update. Accessed March 2020."},{"key":"e_1_2_11_141_1","unstructured":"SunT.News: Abidol and darunavir can effectively inhibit coronavirus.http:\/\/www.sd.chinanews.com\/2\/2020\/0205\/70145.html. Accessed February 21 2020."},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70361-9"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2018.10.002"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00806-5"},{"key":"e_1_2_11_146_1","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.FOCUS14748"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.03.005"},{"key":"e_1_2_11_150_1","unstructured":"Farmaco AId. Azioni intraprese per favorire la ricerca e l'accesso ai nuovi farmaci per il trattamento del COVID\u201019.https:\/\/www.aifa.gov.it\/-\/azioni-intraprese-per-favorire-la-ricerca-e-l-accesso-ai-nuovi-farmaci-per-il-trattamento-del-covid-19. Accessed March 27 2020."},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"e_1_2_11_152_1","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID\u201019: results of an open\u2010label non\u2010randomized clinical trial","volume":"56","author":"Gautret P","year":"2020","journal-title":"Int J Antimicrob Age"},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12586"},{"key":"e_1_2_11_154_1","unstructured":"No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID\u201019.https:\/\/www.recoverytrial.net\/news\/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19. Accessed June 5 2020."},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30894-1"},{"key":"e_1_2_11_156_1","unstructured":"PalcaJ.\"NIH Panel Recommends Against Drug Combination Promoted By Trump For COVID\u201019.https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2020\/04\/21\/840341224\/nih-panel-recommends-against-drug-combination-trump-has-promoted-for-covid-19. April 21 2020."},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01472"},{"key":"e_1_2_11_158_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e79"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_2_11_161_1","unstructured":"No clinical benefit from use of lopinavir\u2010ritonavir in hospitalised COVID\u201019 patients studied in RECOVERY.https:\/\/www.recoverytrial.net\/files\/lopinavir-ritonavir-recovery-statement-29062020_final.pdf. Accessed June 29 2020."},{"key":"e_1_2_11_162_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363080-00004"},{"key":"e_1_2_11_163_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2427-0"},{"key":"e_1_2_11_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11401-2"},{"key":"e_1_2_11_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.07.014"},{"key":"e_1_2_11_166_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.029470"},{"key":"e_1_2_11_167_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_2_11_168_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343"},{"key":"e_1_2_11_169_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"e_1_2_11_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.03.003"},{"key":"e_1_2_11_171_1","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027"},{"key":"e_1_2_11_172_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2020.01012"},{"issue":"2","key":"e_1_2_11_173_1","first-page":"271","article-title":"The novel coronavirus 2019 (2019\u2010nCoV) uses the SARS\u2010coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","volume":"181","author":"Hoffmann M","year":"2020","journal-title":"BioRxiv"},{"key":"e_1_2_11_174_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01815-18"},{"issue":"3","key":"e_1_2_11_175_1","first-page":"179","article-title":"Glucocorticoid\u2010induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy","volume":"43","author":"Xiao JZ","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_2_11_176_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25685"},{"key":"e_1_2_11_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30002-1"},{"key":"e_1_2_11_178_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030623"},{"key":"e_1_2_11_179_1","unstructured":"LiuA.China turns Roche arthritis drug Actemra against COVID\u201019 in new treatment guidelines.https:\/\/www.fiercepharma.com\/pharma-asia\/china-turns-roche-arthritis-drug-actemra-against-covid-19-new-treatment-guidelines. Accessed March 4 2020."},{"key":"e_1_2_11_180_1","first-page":"v1","article-title":"Effective treatment of severe COVID\u201019 patients with Tocilizumab","volume":"202003","author":"Xu X","year":"2020","journal-title":"ChinaXiV"},{"key":"e_1_2_11_181_1","unstructured":"3 patients get better on arthritis drug.http:\/\/www.ansa.it\/english\/news\/general_news\/2020\/03\/13\/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html. Accessed March 5 2020."},{"key":"e_1_2_11_182_1","unstructured":"SolnikC.Northwell Health Initiates Clinical Trials of 2 COVID\u201019 Drugs.https:\/\/www.longislandpress.com\/2020\/03\/21\/northwell-health-initiates-clinical-trials-of-2-covid-19-drugs\/. Accessed March 21 2020."},{"key":"e_1_2_11_183_1","article-title":"Coronavirus disease 2019 (COVID\u201019)","volume":"5","author":"McIntosh K","year":"2020","journal-title":"UpToDate Hirsch MS Bloom"},{"key":"e_1_2_11_184_1","unstructured":"GraingerS.ASCIA Position Statement: Specific Treatments for COVID\u201019.https:\/\/allergy.org.au\/hp\/papers\/specific-treatments-for-covid-19. Accessed July 03 2020."},{"key":"e_1_2_11_185_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01570-8"},{"key":"e_1_2_11_186_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15777"},{"key":"e_1_2_11_187_1","first-page":"1","article-title":"Vitamin D deficiency as risk factor for severe COVID\u201019: a convergence of two pandemics","author":"De Smet D","year":"2020","journal-title":"MedRxiv"},{"key":"e_1_2_11_188_1","first-page":"1","article-title":"Vitamin D insufficiency is prevalent in severe COVID\u201019","year":"2020","journal-title":"medRxiv"},{"key":"e_1_2_11_189_1","first-page":"1","article-title":"Association of vitamin D deficiency and treatment with COVID\u201019 incidence","author":"Meltzer DO","year":"2020","journal-title":"medRxiv"},{"key":"e_1_2_11_190_1","first-page":"1","article-title":"Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID\u201019 patients","author":"Daneshkhah A","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"e_1_2_11_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30183-2"},{"key":"e_1_2_11_192_1","unstructured":"LeeJ Van HeckeO RobertsN.Vitamin D: a rapid review of the evidence for treatment or prevention in COVID\u201019. Centre for Evidence\u2010Based Medicine Website2020."},{"issue":"4","key":"e_1_2_11_193_1","first-page":"e7560","article-title":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID\u201019)","volume":"12","author":"Kakodkar P","year":"2020","journal-title":"Cureus"},{"key":"e_1_2_11_194_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu12040988"},{"key":"e_1_2_11_195_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138003"},{"key":"e_1_2_11_196_1","unstructured":"GrenfellR TrevorD. Here's why it's taking so long to develop a vaccine for the new coronavirus.https:\/\/www.sciencealert.com\/who-says-a-coronavirus-vaccine-is-18-months-away. Accessed February 28 2020."},{"key":"e_1_2_11_197_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-016-0430-6"},{"key":"e_1_2_11_198_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01781"},{"key":"e_1_2_11_199_1","unstructured":"DudduP.Coronavirus outbreak: vaccines\/drugs in the pipeline for Covid\u201019.https:\/\/www.clinicaltrialsarena.com\/analysis\/coronavirus\u2010mers\u2010cov\u2010drugs\/. Accessed February 19 2020."},{"key":"e_1_2_11_200_1","unstructured":"LeeJ.These nine companies are working on coronavirus treatments or vaccines\u2014here's where things stand.https:\/\/www.marketwatch.com\/story\/these-nine-companies-are-working-on-coronavirus-treatments-or-vaccines-heres-where-things-stand-2020-03-06. Accessed March 7 2020."},{"key":"e_1_2_11_201_1","unstructured":"COVID\u201019 vaccine development pipeline.2020.https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/."}],"container-title":["Cell Biochemistry and Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.3591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cbf.3591","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.3591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:07:56Z","timestamp":1760270876000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/cbf.3591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1002\/cbf.3591"],"URL":"https:\/\/doi.org\/10.1002\/cbf.3591","archive":["Portico"],"relation":{},"ISSN":["0263-6484","1099-0844"],"issn-type":[{"value":"0263-6484","type":"print"},{"value":"1099-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"2020-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}